Detalhe da pesquisa
1.
Betibeglogene Autotemcel Gene Therapy for Non-ß0/ß0 Genotype ß-Thalassemia.
N Engl J Med
; 386(5): 415-427, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891223
2.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300386
3.
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
Cytotherapy
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416085
4.
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
J Transl Med
; 20(1): 503, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36329460
5.
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study.
Haematologica
; 107(5): 1054-1063, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162176
6.
Use of the HLA-B leader to optimize cord blood transplantation
Haematologica
; 106(12): 3107-3114, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121238
7.
Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products.
Cytotherapy
; 23(1): 77-87, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32718876
8.
Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT.
Biol Blood Marrow Transplant
; 26(11): 2098-2104, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726672
9.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822845
10.
Opportunities and challenges associated with the evaluation of chimeric antigen receptor T cells in real-life.
Curr Opin Oncol
; 32(5): 427-433, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32665456
11.
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Haematologica
; 105(2): 297-316, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753925
12.
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1810-1817, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128326
13.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128325
14.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576834
15.
Validation of a semi automatic device to standardize quantification of Colony-Forming Unit (CFU) on hematopoietic stem cell products.
Cytotherapy
; 21(8): 820-823, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31257121
16.
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Transfusion
; 59(11): 3442-3447, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31625183
17.
Mobilization and collection of CD34 + cells in patients with globin disorders: Providing the starting material to manufacturers of autologous gene therapies.
Transfus Apher Sci
; 63(3): 103926, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670856
18.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448057
19.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Biol Blood Marrow Transplant
; 24(3): 627-632, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29197681
20.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247781